Top Markets
#1 ADO Protocol ADO Protocol +194.72%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.15%
#6 TENDIES TENDIES +16.67%
#7 Wrapped NXM Wrapped NXM +14.87%
#8 Verus Coin Verus Coin +13.64%
#9 Tutorial Tutorial +13.32%
#10 Pons Pons +12.61%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Kedudukan dalam Saham #33738
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Harga Saham
$4.58
Disegerakkan terakhir: 2025-05-09
Modal Pasaran
$6.98M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan NeuroMetrix, Inc. (NURO)

Kategori

Healthcare
Nisbah P/E bagi NeuroMetrix, Inc. (NURO)
Nisbah P/E pada August 2026 TTM: -1.16
Menurut laporan kewangan dan harga saham terkini NeuroMetrix, Inc., nisbah P/E semasa (TTM) ialah -1.16. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak -0.57.
Sejarah nisbah P/E bagi NeuroMetrix, Inc. dari 2001 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -1.16 15.66%
2024 -1.00 74.47%
2023 -0.57 -76.40%
2022 -2.43 -94.79%
2021 -46.72 -2.30%
2020 -47.82 326.96%
2019 -11.20 -100.58%
2018 1.95K -106,362.74%
2017 -1.83 -31.10%
2016 -2.66 -61.91%
2015 -6.98 -57.39%
2014 -16.38 -5.44%
2013 -17.32 292.25%
2012 -4.42 14.37%
2011 -3.86 -47.92%
2010 -7.41 -73.35%
2009 -27.81 706.91%
2008 -3.45 -96.89%
2007 -110.91 -131.75%
2006 349.34 -87.63%
2005 2.82K -1,170.22%
2004 -263.90 29.91%
2003 -203.14 30.73%
2002 -155.39 81.86%
2001 -85.44 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -3,193.11%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -3,114.21%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -1,949.20%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -1,906.95%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -4,651.59%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.